Efficacy and Safety of AVP-21D9, an Anthrax Monoclonal Antibody, in Animal Models and Humans

Anthrax is an acute infectious disease caused by the spore-forming bacterium Bacillus anthracis. Timely administration of antibiotics approved for the treatment of anthrax disease may prevent associated morbidity and mortality. However, any delay in initiating antimicrobial therapy may result in inc...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Malkevich, Nina V., Hopkins, Robert J., Bernton, Edward, Meister, Gabriel T., Vela, Eric M., Atiee, George, Johnson, Virginia, Nabors, Gary S., Aimes, Ronald T., Ionin, Boris, Skiadopoulos, Mario H.
Format: Artigo
Jezik:Inglês
Izdano: American Society for Microbiology 2014
Teme:
Experimental Therapeutics
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4068543/
https://ncbi.nlm.nih.gov/pubmed/24733473
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02295-13
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki